- Home
- ARQT vs BY Comparison
ARQT vs BY Comparison
Compare ARQT & BY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- BY
- Stock Information
- Founded
- ARQT 2016
- BY 1914
- Country
- ARQT United States
- BY United States
- Employees
- ARQT N/A
- BY N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- BY Major Banks
- Sector
- ARQT Health Care
- BY Finance
- Exchange
- ARQT Nasdaq
- BY Nasdaq
- Market Cap
- ARQT 1.1B
- BY 1.2B
- IPO Year
- ARQT 2020
- BY 2017
- Fundamental
- Price
- ARQT $14.99
- BY $29.17
- Analyst Decision
- ARQT Strong Buy
- BY Hold
- Analyst Count
- ARQT 4
- BY 3
- Target Price
- ARQT $15.50
- BY $32.00
- AVG Volume (30 Days)
- ARQT 2.2M
- BY 122.0K
- Earning Date
- ARQT 11-06-2024
- BY 01-23-2025
- Dividend Yield
- ARQT N/A
- BY 1.23%
- EPS Growth
- ARQT N/A
- BY 6.38
- EPS
- ARQT N/A
- BY 2.76
- Revenue
- ARQT $138,708,000.00
- BY $373,634,000.00
- Revenue This Year
- ARQT $208.32
- BY N/A
- Revenue Next Year
- ARQT $48.56
- BY $3.24
- P/E Ratio
- ARQT N/A
- BY $10.59
- Revenue Growth
- ARQT 182.84
- BY 9.77
- 52 Week Low
- ARQT $2.60
- BY $19.70
- 52 Week High
- ARQT $15.77
- BY $32.89
- Technical
- Relative Strength Index (RSI)
- ARQT 67.53
- BY 38.22
- Support Level
- ARQT $12.66
- BY $30.88
- Resistance Level
- ARQT $15.02
- BY $31.48
- Average True Range (ATR)
- ARQT 1.11
- BY 0.79
- MACD
- ARQT 0.14
- BY -0.41
- Stochastic Oscillator
- ARQT 78.92
- BY 18.18
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About BY Byline Bancorp Inc.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium-sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to our customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.